4//SEC Filing
LINDSTROM RICHARD L MD 4
Accession 0001104659-24-083104
CIK 0001393434other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 7:30 PM ET
Size
15.7 KB
Accession
0001104659-24-083104
Insider Transaction Report
Form 4
LINDSTROM RICHARD L MD
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-27$8.80/sh+18,939$166,663→ 139,341 total - Award
Common Stock
2024-07-24+12,000→ 162,704 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-27−18,939→ 0 totalExercise: $8.80Exp: 2024-04-13→ Common Stock (18,939 underlying) - Exercise/Conversion
Common Stock
2024-02-27$8.80/sh+11,363$99,994→ 150,704 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-27−11,363→ 0 totalExercise: $8.80Exp: 2024-04-13→ Common Stock (11,363 underlying) - Award
Stock Option (Right to Buy)
2024-07-24+36,000→ 36,000 totalExercise: $7.91Exp: 2034-07-23→ Common Stock (36,000 underlying)
Footnotes (4)
- [F1]On July 24, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
- [F2]On February 27, 2024, the reporting person exercised an option to purchase 18,939 shares of the Company's common stock. The option was granted on April 14, 2014, and vested over four years, with 25% of the shares underlying the option vesting on April 11, 2015, and vesting monthly thereafter.
- [F3]On February 27, 2024, the reporting person exercised an option to purchase 11,363 shares of the Company's common stock. The option was granted on April 14, 2014, and vested over three years, vesting monthly beginning on the one-month anniversary of the Company's initial public offering.
- [F4]Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0001242177
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 7:30 PM ET
- Size
- 15.7 KB